These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38469260)

  • 1. Rotigotine is effective for depressive symptoms accompanying periodic limb movement disorder or restless legs syndrome.
    Miura J; Honma KI; Honma S
    Sleep Biol Rhythms; 2022 Apr; 20(2):315-317. PubMed ID: 38469260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.
    Littner MR; Kushida C; Anderson WM; Bailey D; Berry RB; Hirshkowitz M; Kapen S; Kramer M; Lee-Chiong T; Li KK; Loube DL; Morgenthaler T; Wise M;
    Sleep; 2004 May; 27(3):557-9. PubMed ID: 15164914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic limb movement disorder and restless legs syndrome in dialysis patients.
    Rijsman RM; de Weerd AW; Stam CJ; Kerkhof GA; Rosman JB
    Nephrology (Carlton); 2004 Dec; 9(6):353-61. PubMed ID: 15663636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of Parasomnias After Treatment of Restless Leg Syndrome/ Periodic Limb Movement Disorder in Children.
    Gurbani N; Dye TJ; Dougherty K; Jain S; Horn PS; Simakajornboon N
    J Clin Sleep Med; 2019 May; 15(5):743-748. PubMed ID: 31053208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of long-term iron supplementation in pediatric restless legs syndrome/periodic limb movement disorder (RLS/PLMD).
    Dye TJ; Jain SV; Simakajornboon N
    Sleep Med; 2017 Apr; 32():213-219. PubMed ID: 27282843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of restless legs syndrome in children.
    Simakajornboon N; Kheirandish-Gozal L; Gozal D
    Sleep Med Rev; 2009 Apr; 13(2):149-56. PubMed ID: 19186083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.
    Garcia-Borreguero D; Allen R; Hudson J; Dohin E; Grieger F; Moran K; Schollmayer E; Smit R; Winkelman J
    Curr Med Res Opin; 2016; 32(1):77-85. PubMed ID: 26569149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep.
    Vignatelli L; Billiard M; Clarenbach P; Garcia-Borreguero D; Kaynak D; Liesiene V; Trenkwalder C; Montagna P;
    Eur J Neurol; 2006 Oct; 13(10):1049-65. PubMed ID: 16987157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic limb movements and restless legs syndrome in children with a history of prematurity.
    Cielo CM; DelRosso LM; Tapia IE; Biggs SN; Nixon GM; Meltzer LJ; Traylor J; Kim JY; Marcus CL;
    Sleep Med; 2017 Feb; 30():77-81. PubMed ID: 28215268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs.
    Picchietti DL; Rajendran RR; Wilson MP; Picchietti MA
    Sleep Med; 2009 Sep; 10(8):925-31. PubMed ID: 19332386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
    Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
    Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daytime symptoms of restless legs syndrome--clinical characteristics and rotigotine effectiveness.
    Takahashi M; Ikeda J; Tomida T; Hirata K; Hattori N; Inoue Y
    Sleep Med; 2015 Jul; 16(7):871-6. PubMed ID: 26002761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
    DelRosso LM; Ferri R; Chen ML; Kapoor V; Allen RP; Mogavero MP; Picchietti DL
    Sleep Med; 2021 Nov; 87():114-118. PubMed ID: 34562823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large body movements on video polysomnography are associated with daytime dysfunction in children with restless sleep disorder.
    Liu WK; Dye TJ; Horn P; Patterson C; Garner D; Simakajornboon N
    Sleep; 2022 Apr; 45(4):. PubMed ID: 35022768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.
    Salminen AV; Winkelmann J
    Curr Treat Options Neurol; 2018 Nov; 20(12):55. PubMed ID: 30411165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder.
    Stiasny K; Oertel WH; Trenkwalder C
    Sleep Med Rev; 2002 Aug; 6(4):253-65. PubMed ID: 12531131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
    Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
    Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restless legs syndrome, periodic limb movements, and psychopharmacology].
    Cohrs S; Rodenbeck A; Hornyak M; Kunz D
    Nervenarzt; 2008 Nov; 79(11):1263-4, 1266-72. PubMed ID: 18958441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of rotigotine in the treatment of restless legs syndrome.
    Serafini A; Lorenzut S; Gigli GL; Merlino G; Valente M
    Ther Adv Neurol Disord; 2010 Jul; 3(4):241-8. PubMed ID: 21179615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.